Evaluation

1) Using the scale below, please rate this CME activity *

1=Very Poor, 5=Excellent

	Very Poor	Poor	Neutral	Good	Excellent
Overall Evaluation	Overall Evaluation - Very Poor	Overall Evaluation - Poor	Overall Evaluation - Neutral	Overall Evaluation - Good	Overall Evaluation - Excellent
Content	Content - Very Poor	Content - Poor	Content - Neutral	Content - Good	Content - Excellent
Usefulness	Usefulness - Very Poor	Usefulness - Poor	Usefulness - Neutral	Usefulness - Good	Usefulness - Excellent
Quality	Quality - Very Poor	Quality - Poor	Quality - Neutral	Quality - Good	Quality - Excellent

2) Please rate the extent to which each of the following learning objectives were met. *

1=Strongly Disagree, 5= Strongly Agree

	1	2	3	4	5
Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer	Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer - 1	Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer - 2	Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer - 3	Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer - 4	Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer - 5
Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection	Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection - 1	Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection - 2	Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection - 3	Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection - 4	Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection - 5
Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer	Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer - 1	Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer - 2	Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer - 3	Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer - 4	Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer - 5

3) How many patients do you see with breast cancer each month? *

4) After participating in this activity, please use the below scale to rate your level of confidence in your ability to: *

(1=Not confident at all, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=Extremely confident, N/A=Not within the scope of my practice)

	1	2	3	4	5	N/A
develop personalized treatment plans for patients with breast cancer	develop personalized treatment plans for patients with breast cancer - 1	develop personalized treatment plans for patients with breast cancer - 2	develop personalized treatment plans for patients with breast cancer - 3	develop personalized treatment plans for patients with breast cancer - 4	develop personalized treatment plans for patients with breast cancer - 5	develop personalized treatment plans for patients with breast cancer - N/A
recognize and identify specific biomarkers in metastatic and triple negative breast cancer	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - 1	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - 2	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - 3	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - 4	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - 5	recognize and identify specific biomarkers in metastatic and triple negative breast cancer - N/A

6) As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with breast cancer. *

Yes

No

7) Do you feel the activity was fair balanced and free of commercial bias? *

Yes

No

If no, please explain.

8) What topics would you like to see in future CME activities?

9) Do you wish to be notified by email when new educational programs are offered by Elsevier?

Yes

No

10) Using the scale below, please indicate how often you plan to use each of the following clinical practice strategies for your patients with breast cancer. *

1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me

	1	2	3	4	5	N/A
Identify clinical classifications and biomarkers when assessing subtypes of breast cancer	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - 1	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - 2	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - 3	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - 4	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - 5	Identify clinical classifications and biomarkers when assessing subtypes of breast cancer - N/A
Utilize patient screening strategies in order to manage patients effectively	Utilize patient screening strategies in order to manage patients effectively - 1	Utilize patient screening strategies in order to manage patients effectively - 2	Utilize patient screening strategies in order to manage patients effectively - 3	Utilize patient screening strategies in order to manage patients effectively - 4	Utilize patient screening strategies in order to manage patients effectively - 5	Utilize patient screening strategies in order to manage patients effectively - N/A
Apply current clinical trial data to appropriately manage patients with breast cancer	Apply current clinical trial data to appropriately manage patients with breast cancer - 1	Apply current clinical trial data to appropriately manage patients with breast cancer - 2	Apply current clinical trial data to appropriately manage patients with breast cancer - 3	Apply current clinical trial data to appropriately manage patients with breast cancer - 4	Apply current clinical trial data to appropriately manage patients with breast cancer - 5	Apply current clinical trial data to appropriately manage patients with breast cancer - N/A

Elsevier CME

Course Video

Course navigation

You are here

Evaluation

Course Video

Course navigation